 Transfusion Reaction
"Transfusion Reaction" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Complications of BLOOD TRANSFUSION. Included adverse reactions are common allergic and febrile reactions; hemolytic (delayed and acute) reactions; and other non-hemolytic adverse reactions such as infections and adverse immune reactions related to immunocompatibility.
| Descriptor ID |
D065227
|
| MeSH Number(s) |
C15.378.962 C20.920
|
| Concept/Terms |
Transfusion Reaction- Transfusion Reaction
- Transfusion Reactions
- Blood Transfusion-Associated Adverse Reactions
- Blood Transfusion Associated Adverse Reactions
Hemolytic Transfusion Reaction- Hemolytic Transfusion Reaction
- Hemolytic Transfusion Reactions
- Reaction, Hemolytic Transfusion
- Reactions, Hemolytic Transfusion
- Transfusion Reaction, Hemolytic
- Transfusion Reactions, Hemolytic
Transfusion-Transmitted Infection- Transfusion-Transmitted Infection
- Infection, Transfusion-Transmitted
- Transfusion Transmitted Infection
- Transfusion-Transmitted Infections
Transfusion-Associated Circulatory Overload- Transfusion-Associated Circulatory Overload
- Circulatory Overload, Transfusion-Associated
- Circulatory Overloads, Transfusion-Associated
- Transfusion Associated Circulatory Overload
- Transfusion-Associated Circulatory Overloads
Hypotensive Transfusion Reaction- Hypotensive Transfusion Reaction
- Reaction, Hypotensive Transfusion
- Transfusion Reaction, Hypotensive
- Transfusion Reactions, Hypotensive
|
Below are MeSH descriptors whose meaning is more general than "Transfusion Reaction".
Below are MeSH descriptors whose meaning is more specific than "Transfusion Reaction".
This graph shows the total number of publications written about "Transfusion Reaction" by people in this website by year, and whether "Transfusion Reaction" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 0 | 1 | | 1990 | 1 | 0 | 1 | | 1991 | 1 | 0 | 1 | | 1993 | 1 | 1 | 2 | | 1995 | 1 | 0 | 1 | | 1997 | 1 | 1 | 2 | | 1998 | 1 | 0 | 1 | | 1999 | 1 | 1 | 2 | | 2000 | 1 | 0 | 1 | | 2001 | 2 | 0 | 2 | | 2002 | 3 | 0 | 3 | | 2003 | 1 | 0 | 1 | | 2004 | 2 | 0 | 2 | | 2005 | 3 | 0 | 3 | | 2006 | 2 | 1 | 3 | | 2007 | 0 | 2 | 2 | | 2008 | 1 | 1 | 2 | | 2009 | 4 | 1 | 5 | | 2010 | 2 | 1 | 3 | | 2011 | 4 | 1 | 5 | | 2012 | 6 | 0 | 6 | | 2013 | 1 | 1 | 2 | | 2014 | 1 | 1 | 2 | | 2016 | 0 | 2 | 2 | | 2017 | 0 | 2 | 2 | | 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Transfusion Reaction" by people in Profiles.
-
Castro G, Merkel PA, Giclas HE, Gibula A, Andersen GE, Corash LM, Lin JS, Green J, Knight V, Stassinopoulos A. Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease. Transfusion. 2018 06; 58(6):1506-1515.
-
Vostal JG, Buehler PW, Gelderman MP, Alayash AI, Doctor A, Zimring JC, Glynn SA, Hess JR, Klein H, Acker JP, Spinella PC, D'Alessandro A, Palsson B, Raife TJ, Busch MP, McMahon TJ, Intaglietta M, Swartz HM, Dubick MA, Cardin S, Patel RP, Natanson C, Weisel JW, Muszynski JA, Norris PJ, Ness PM. Proceedings of the Food and Drug Administration's public workshop on new red blood cell product regulatory science 2016. Transfusion. 2018 01; 58(1):255-266.
-
Vora AN, Stanislawski M, Grunwald GK, Plomondon ME, Rumsfeld JS, Maddox TM, Vidovich MI, Woody W, Nallamothu BK, Gurm HS, Rao SV. Association Between Chronic Kidney Disease and Rates of Transfusion and Progression to End-Stage Renal Disease in Patients Undergoing Transradial Versus Transfemoral Cardiac Catheterization-An Analysis From the Veterans Affairs Clinical Assessment Reporting and Tracking (CART) Program. J Am Heart Assoc. 2017 Apr 18; 6(4).
-
Kelher MR, Banerjee A, Gamboni F, Anderson C, Silliman CC. Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model. Transfusion. 2016 12; 56(12):3004-3011.
-
Dunbar NM, Dumont LJ, Szczepiorkowski ZM. How do we implement Day 6 and Day 7 platelets at a hospital-based transfusion service? Transfusion. 2016 06; 56(6):1262-6.
-
Frisch NB, Wessell NM, Charters MA, Yu S, Jeffries JJ, Silverton CD. Predictors and complications of blood transfusion in total hip and knee arthroplasty. J Arthroplasty. 2014 Sep; 29(9 Suppl):189-92.
-
Fong DL, Torrence AE, Vogel KW, Stockinger DE, Nelson V, Murnane RD, Baldessari A, Kuller L, Agy M, Kiem HP, Hotchkiss CE. Transmission of Chagas disease via blood transfusions in 2 immunosuppressed pigtailed macaques (Macaca nemestrina). Comp Med. 2014 Feb; 64(1):63-7.
-
Silliman CC, Bercovitz RS, Khan SY, Kelher MR, LaSarre M, Land KJ, Sowemimo-Coker S. Antibodies to the HLA-A2 antigen prime neutrophils and serve as the second event in an in vitro model of transfusion-related acute lung injury. Vox Sang. 2014 Jul; 107(1):76-82.
-
Young H, Knepper B, Vigil C, Miller A, Carey JC, Price CS. Sustained reduction in surgical site infection after abdominal hysterectomy. Surg Infect (Larchmt). 2013 Oct; 14(5):460-3.
-
Silliman CC, Kelher M, Ambruso DR. Bioactive lipids from stored cellular blood components: in vitro method is crucial for proper interpretation. Transfusion. 2012 May; 52(5):1155-7; author reply 1157-8.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|